Image Place holder

Louis B. Harrison, MD, FASTRO

Chair, Department of Radiation Oncology
Deputy Physician-in-Chief
Chief, Radiation Oncology Service
Vice President, Chief Partnership Officer

Specialty: Radiation Oncology
Program: Radiation Oncology

Call 1-888-MOFFITT

Call 1-888-MOFFITT

Locations: Moffitt Cancer Center

Cancer Types Treated: Basal Cell Carcinoma , Head and Neck Cancer , Melanoma , Merkel Cell Carcinoma , Oral Cavity or Throat Cancer , Sarcoma , Skin Cancer (Nonmelanoma) , Throat Cancer, Tongue Cancer

Dr. Harrison is the Chair of the Department of Radiation Oncology at Moffitt Cancer Center. He is also Deputy Physician in Chief at Moffitt. In this role, he is part of the Moffitt Medical Group Leadership team.  Dr. Harrison is also Moffitt's Vice President, Chief Partnership Officer. In this capacity, he works to develop multifaceted partnership and strategic alliances that advance the cancer center’s strategic goals and increase patient access to the institution. He received his MD degree from the S.U.N.Y. Downstate Medical Center College of Medicine. He completed a Radiation Oncology Residency at Yale University School of Medicine, Yale-New Haven Hospital; and also served as Chief Resident. Following residency, Dr. Harrison joined the faculty at Memorial Sloan-Kettering Cancer Center in New York. While at Memorial, he was the Chief of the Brachytherapy Service in the Department of Radiation Oncology as well as the Institutional Program Leader of the multidisciplinary Head and Neck Cancer Disease Management Team. He joined the Continuum Health Partners (Beth Israel Medical Center, St. Luke's and Roosevelt Hospitals and NY Eye and Ear Infirmary) in 1997. At Continuum, Dr. Harrison served as Chairman and Gerald J. Friedman Endowed Chair of Radiation Oncology and Physician-in-Chief of Continuum Cancer Centers of New York. Dr. Harrison was also appointed as Professor of Radiation Oncology and Otorhinolaryngology-Head and Neck Surgery at the Albert Einstein College of Medicine. He has served as Chairman of the Board and President of ASTRO, the leading radiation oncology professional society in the country, as well as President of the American Brachytherapy Society and President of the International Society of Intraoperative Radiation Therapy. The American Society for Radiation Oncology (ASTRO) named Dr. Harrison as a 2017 ASTRO Gold Medalist, the highest honor bestowed upon ASTRO members who have made outstanding lifetime contributions in the field of radiation oncology.  Dr. Harrison serves on the Board of Directors of the National Comprehensive Cancer Network (NCCN), where he also has been elected to the Executive Committee. Dr Harrison is the senior editor of the textbook Head and Neck Cancer: A Multidisciplinary Approach, now in its fourth edition. He is also a co-editor of Intraoperative Irradiation: Techniques and Results, now in its second edition. Dr Harrison has received numerous awards including the Alpha Omega Alpha Honor Medical Society, Clarence Dennis Society Prize, and the Henscke Award for Brachytherapy, the Physician of Excellence Award from the American Cancer Society and the Boyer Prize for Biomedical Research at Memorial Sloan Kettering Cancer Center. 

Education & Training

Board Certification:

  • Radiation Oncology


  • Yale University School of Medicine - Therapeutic Radiology

Medical School:

  • SUNY Downstate Medical Center - MD
Participating Trials

Phase II Randomized Trial of Radiotherapy with or without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) with TP53 Sequencing
Condition: Head & Neck
Intervention: Radiotherapy; cisplatin

Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy Fractionation for Patients with HPV+ Oropharyngeal Cancers.
Condition: Head & Neck

A Phase 2, Randomized, Multi-institutional Study of Nivolumab and Ipilimumab versus Nivolumab, Ipilimumab and Stereotactic Body Radiation Therapy for Metastatic Merkel Cell Carcinoma
Condition: Cutaneous
Intervention: BMS-936558 (Nivolumab); Ipilimumab; Nivolumab; Yervoy (Ipilimumab)

Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Stage III-IVB Head and Neck Cancer with a Contraindication to Cisplatin
Condition: Head & Neck
Intervention: AMP-514 (Durvalumab); Cetuximab; Durvalumab; Erbitux (Cetuximab); MEDI4736 (Durvalumab)

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.


  • Mendenhall WM, Strojan P, Beitler JJ, Langendijk JA, Suarez C, Lee AW, Rinaldo A, Rodrigo JP, Smee R, Eisbruch A, Harrison LB, Corry J, Ferlito A. Radiotherapy for parapharyngeal space tumors. Am J Otolaryngol. 2019 Mar;40(2):289-291. Pubmedid: 30621929.
  • Perez MC, Oliver DE, Weitman ES, Boulware D, Messina JL, Torres-Roca J, Cruse CW, Gonzalez RJ, Sarnaik AA, Sondak VK, Wuthrick EJ, Harrison LB, Zager JS. Management of Sentinel Lymph Node Metastasis in Merkel Cell Carcinoma: Completion Lymphadenectomy, Radiation, or Both?. Ann Surg Oncol. 2019 Feb;26(2):379-385. Pubmedid: 30311164.
  • Enderling H, Alfonso JCL, Moros E, Caudell JJ, Harrison LB. Integrating Mathematical Modeling into the Roadmap for Personalized Adaptive Radiation Therapy. Trends Cancer. 2019 Aug;5(8):467-474. Pubmedid: 31421904.
  • Grass GD, Mills MN, Ahmed KA, Liveringhouse CL, Montejo ME, Robinson TJ, Chavez JC, Harrison LB, Kim S. Radiotherapy for early stage diffuse large B-cell lymphoma with or without double or triple hit genetic alterations. Leuk Lymphoma. 2019 Apr;60(4):886-893. Pubmedid: 30457458. Pmcid: PMC6596288.
  • Oliver DE, Mohammadi H, Figura N, Frakes JM, Yamoah K, Perez BA, Wuthrick EJ, Naghavi AO, Caudell JJ, Harrison LB, Torres-Roca JF, Ahmed KA. Novel Genomic-Based Strategies to Personalize Lymph Node Radiation Therapy. Semin Radiat Oncol. 2019 Apr;29(2):111-125. Pubmedid: 30827449.
  • López Alfonso JC, Poleszczuk J, Walker R, Kim S, Pilon-Thomas S, Conejo-Garcia JJ, Soliman H, Czerniecki B, Harrison LB, Enderling H. Immunologic Consequences of Sequencing Cancer Radiotherapy and Surgery. JCO Clin Cancer Inform. 2019 Apr;3:1-16. Pubmedid: 30964698. Pmcid: PMC6661069.
  • Wuthrick EJ, Harrison LB. A Deep Dive into the Diagnosis and Management of Regional Lymph Node Metastases. Semin Radiat Oncol. 2019 04;29(2):91-92. Pubmedid: 30827457.
  • Perez MC, de Pinho FR, Holstein A, Oliver DE, Naqvi SMH, Kim Y, Messina JL, Burke E, Gonzalez RJ, Sarnaik AA, Cruse CW, Wuthrick EJ, Harrison LB, Sondak VK, Zager JS. Resection Margins in Merkel Cell Carcinoma: Is a 1-cm Margin Wide Enough?. Ann Surg Oncol. 2018 Oct;25(11):3334-3340. Pubmedid: 30073600.
  • Naghavi AO, Echevarria MI, Strom TJ, Abuodeh YA, Venkat PS, Ahmed KA, Demetriou S, Frakes JM, Kim Y, Kish JA, Russell JS, Otto KJ, Chung CH, Harrison LB, Trotti A, Caudell JJ. Patient choice for high-volume center radiation impacts head and neck cancer outcome. Cancer Med. 2018 Oct;7(10):4964-4979. Pubmedid: 30175512. Pmcid: PMC6198196.
  • Sher DJ, Adelstein DJ, Bajaj GK, Brizel DM, Cohen EE, Halthore A, Harrison LB, Lu C, Moeller BJ, Quon H, Rocco JW, Sturgis EM, Tishler RB, Trotti A, Waldron J, Eisbruch A. Response to ASTRO consensus guideline for oropharyngeal cancer: In Regard to Walker et al. Pract Radiat Oncol. 2018 Nov;8(3):e185-e186. Pubmedid: 29724403.
  • Sher DJ, Adelstein DJ, Bajaj GK, Brizel DM, Cohen EEW, Halthore A, Harrison LB, Lu C, Moeller BJ, Quon H, Rocco JW, Sturgis EM, Tishler RB, Trotti A, Waldron J, Eisbruch A. Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice Guideline. Pract Radiat Oncol. 2018 Mar;7(4):246-253. Pubmedid: 28428019.
  • Oliver DE, Sondak VK, Strom T, Zager JS, Naghavi AO, Sarnaik A, Messina JL, Caudell JJ, Trotti AM, Torres-Roca JF, Khushalani NI, Harrison LB. Interferon is associated with improved survival for node-positive cutaneous melanoma: a single-institution experience. Melanoma Manag. 2018 Jun;5(1):MMT02. Pubmedid: 30190928. Pmcid: PMC6122528.
  • Naghavi AO, Fernandez DC, Mesko N, Juloori A, Martinez A, Scott JG, Shah C, Harrison LB. American Brachytherapy Society consensus statement for soft tissue sarcoma brachytherapy. Brachytherapy. 2018 Jan;16(3):466-489. Pubmedid: 28342738.
  • Rossetti A, Chadha M, Torres BN, Lee JK, Hylton D, Loewy JV, Harrison LB. The Impact of Music Therapy on Anxiety in Cancer Patients Undergoing Simulation for Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017 Sep;99(1):103-110. Pubmedid: 28816136.
  • Strom T, Harrison LB, Giuliano AR, Schell MJ, Eschrich SA, Berglund A, Fulp W, Thapa R, Coppola D, Kim S, Frakes J, Foekens J, Mulé JJ, Torres-Roca JF. Tumour radiosensitivity is associated with immune activation in solid tumours. Eur J Cancer. 2017 Oct;84:304-314. Pubmedid: 28863385. Pmcid: PMC5822441.
  • Caudell JJ, Torres-Roca JF, Gillies RJ, Enderling H, Kim S, Rishi A, Moros EG, Harrison LB. The future of personalised radiotherapy for head and neck cancer. Lancet Oncol. 2017 May;18(5):e266-e273. Pubmedid: 28456586.
  • Ahmed KA, Kim S, Arrington J, Naghavi AO, Dilling TJ, Creelan BC, Antonia SJ, Caudell JJ, Harrison LB, Sahebjam S, Gray JE, Etame AB, Johnstone PA, Yu M, Perez BA. Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases. J Neurooncol. 2017 Jun;133(2):331-338. Pubmedid: 28466250.
  • Poleszczuk J, Luddy K, Chen L, Lee JK, Harrison LB, Czerniecki BJ, Soliman H, Enderling H. Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival. Breast Cancer Res. 2017 Jun;19(1):75. Pubmedid: 28666457. Pmcid: PMC5493088.
  • Naghavi AO, Gonzalez RJ, Scott JG, Mullinax JE, Abuodeh YA, Kim Y, Binitie O, Ahmed KA, Bui MM, Saini AS, Zager JS, Biagioli MC, Letson D, Harrison LB, Fernandez DC. Implications of staged reconstruction and adjuvant brachytherapy in the treatment of recurrent soft tissue sarcoma. Brachytherapy. 2017 Jul;15(4):495-503. Pubmedid: 27180128.
  • Ahmed KA, Kim S, Harrison LB. Novel Opportunities to Use Radiation Therapy with Immune Checkpoint Inhibitors for Melanoma Management. Surg Oncol Clin N Am. 2017 Jul;26(3):515-529. Pubmedid: 28576186.
  • Hu KS, Mourad WF, Gamez ME, Lin W, Jacobson AS, Persky MS, Urken ML, Culliney BE, Li Z, Tran TN, Schantz SP, Chadha J, Harrison LB. Five-year outcomes of an oropharynx-directed treatment approach for unknown primary of the head and neck. Oral Oncol. 2017 Jul;70:14-22. Pubmedid: 28622886.
  • Strom T, Naghavi AO, Messina JL, Kim S, Torres-Roca JF, Russell J, Sondak VK, Padhya TA, Trotti AM, Caudell JJ, Harrison LB. Improved local and regional control with radiotherapy for Merkel cell carcinoma of the head and neck. Head Neck. 2017 Jan;39(1):48-55. Pubmedid: 27300153.
  • Strom TJ, Naghavi AO, Trotti AM, Russell J, Kish JA, McCaffrey J, Otto KJ, Harrison LB, Caudell JJ. Increased acute mortality with chemoradiotherapy for locally advanced head and neck cancer in patients ≥70years. Geriatr Oncol. 2017 Jan;8(1):50-55. Pubmedid: 27720129.
  • Scott JG, Berglund A, Schell MJ, Mihaylov I, Fulp WJ, Yue B, Welsh E, Caudell JJ, Ahmed K, Strom TS, Mellon E, Venkat P, Johnstone P, Foekens J, Lee J, Moros E, Dalton WS, Eschrich SA, McLeod H, Harrison LB, Torres-Roca JF. A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study. Lancet Oncol. 2017 Feb;18(2):202-211. Pubmedid: 27993569.
  • Gamez ME, Agarwal M, Hu KS, Lukens JN, Harrison LB. Hypofractionated Palliative Radiotherapy with Concurrent Radiosensitizing Chemotherapy for Advanced Head and Neck Cancer Using the "QUAD-SHOT Regimen". Anticancer Res. 2017 Feb;37(2):685-691. Pubmedid: 28179317.
  • Naghavi AO, Gonzalez RJ, Scott JG, Kim Y, Abuodeh YA, Strom TJ, Echevarria M, Mullinax JE, Ahmed KA, Harrison LB, Fernandez DC. Staged reconstruction brachytherapy has lower overall cost in recurrent soft-tissue sarcoma. J Contemp Brachytherapy. 2017 Feb;9(1):20-29. Pubmedid: 28344600. Pmcid: PMC5346606.
  • Takácsi-Nagy Z, Martínez-Mongue R, Mazeron JJ, Anker CJ, Harrison LB. American Brachytherapy Society Task Group Report: Combined external beam irradiation and interstitial brachytherapy for base of tongue tumors and other head and neck sites in the era of new technologies. Brachytherapy. 2017 Aug;16(1):44-58. Pubmedid: 27592129.
  • Hu KS, Mourad WF, Gamez M, Safdieh J, Lin W, Jacobson AS, Persky MS, Urken ML, Culliney B, Li Z, Tran TN, Schantz SP, Chadha J, Harrison LB. Low rates of contralateral neck failure in unilaterally treated oropharyngeal squamous cell carcinoma with prospectively defined criteria of lateralization. Head Neck. 2017 Aug;39(8):1647-1654. Pubmedid: 28474380.
  • Strom T, Torres-Roca JF, Parekh A, Naghavi AO, Caudell JJ, Oliver DE, Messina JL, Khushalani NI, Zager JS, Sarnaik A, Mulé JJ, Trotti AM, Eschrich SA, Sondak VK, Harrison LB. Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous Melanoma. J Natl Compr Canc Ne. 2017 Apr;15(4):473-482. Pubmedid: 28404758.
  • Abuodeh Y, Ahmed K, Echevarria M, Naghavi A, Grass GD, Robinson TJ, Tomblyn M, Shah B, Chavez J, Bello C, El-Haddad G, Harrison L, Kim S. Priming radioimmunotherapy with external beam radiation in patients with relapsed low grade non-Hodgkin lymphoma. Ther Adv Hematol. 2017 Apr;8(4):129-138. Pubmedid: 28491264. Pmcid: PMC5405899.
  • Parikh RR, Grossbard ML, Harrison LB, Yahalom J. In Reply to Zhang. Int J Radiat Oncol Biol Phys. 2017 10;99(2):501. Pubmedid: 28872005.
  • Scott JG, Harrison LB, Torres-Roca JF. Genomic biomarkers for precision radiation medicine - Authors' reply. Lancet Oncol. 2017 05;18(5):e239. Pubmedid: 28495285.
  • Scott JG, Harrison LB, Torres-Roca JF. Genomic-adjusted radiation dose - Authors' reply. Lancet Oncol. 2017 03;18(3):e129. Pubmedid: 28271862.
  • Harrison LB. Clinical Trial or Unilateral RT with Cisplatin. Int J Radiat Oncol Biol Phys. 2017 01;97(1):5. Pubmedid: 27979457.
  • Parikh RR, Goodman RR, Rhome R, Sudentas E, Trichter F, Harrison LB, Choi W. Linear accelerator-based flattening-filter-free stereotactic radiosurgery for trigeminal neuralgia: Feasibility and patient-reported outcomes. Pract Radiat Oncol. 2016 Oct;6(1):e1-e7. Pubmedid: 26577003.
  • Mourad WF, Patel S, Young R, Khorsandi AS, Concert C, Shourbaji RA, Ciarrocca K, Bakst RL, Shasha D, Guha C, Garg MK, Hu KS, Kalnicki S, Harrison LB. Management algorithm for HIV-associated parotid lymphoepithelial cysts. Eur Arch Otorhinolaryngol. 2016 Oct;273(10):3355-3362. Pubmedid: 26879995.
  • Strom T, Carr M, Zager JS, Naghavi A, Smith FO, Cruse CW, Messina JL, Russell J, Rao NG, Fulp W, Kim S, Torres-Roca JF, Padhya TA, Sondak VK, Trotti AM, Harrison LB, Caudell JJ. Radiation Therapy is Associated with Improved Outcomes in Merkel Cell Carcinoma. Ann Surg Oncol. 2016 Oct;23(11):3572-3578. Pubmedid: 27251134.
  • Grass GD, Peacock J, Latifi K, Zhang GG, Mills M, Garcia G, Harrison LB, Kim S. Spatial Patterns of Local Failure Following Chemotherapy in Hodgkin Lymphoma: Volume Reduction From Involved Site/Nodal Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016 Oct;96(2S):S39. Pubmedid: 27675917.
  • Ahmed KA, Strom T, Scott JG, Welsh EA, McLeod HL, Harrison LB, Eschrich SA, Torres-Roca JF. The Radiosensitivity Index (RSI) and the Connectivity Map: A Genomically Guided Approach for the Identification of Novel Radiosensitizers. Int J Radiat Oncol Biol Phys. 2016 Oct;96(2S):S236. Pubmedid: 27675869.
  • Scott JG, Torres-Roca JF, Harrison LB, Berglund AE, Schell M, Mihaylov IB, Fulp WJ, Yue B, Welsh EA, Caudell JJ, Ahmed KA, Strom T, Mellon EA, Venkat PS, Johnstone PA, Moros EG, Lee J, Foekens J, Dalton WS, Eschrich SA, McLeod HL. A Genomic Framework for Precision Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016 Oct;96(2S):S215-S216. Pubmedid: 27675815.
  • Abuodeh YA, Ahmed KA, Echevarria M, Naghavi AO, Grass GD, Tomblyn MB, Harrison LB, Kim S. Priming Radioimmunotherapy With External Beam Radiation in Patients With Relapsed Low-Grade Non-Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys. 2016 Oct;96(2S):S164. Pubmedid: 27675684.
  • Parekh A, Strom T, Naghavi AO, Caudell JJ, Zager JS, Messina JL, Torres-Roca JF, Sondak VK, Trotti A, Harrison LB. Does Regional Radiation Therapy Impact Outcome for High-Risk, Node-Positive Cutaneous Melanoma?. Int J Radiat Oncol Biol Phys. 2016 Oct;96(2S):S157. Pubmedid: 27675666.
  • Naghavi AO, Echevarria M, Strom T, Abuodeh YA, Ahmed KA, Venkat PS, Trotti A, Harrison LB, Green BL, Yamoah K, Caudell JJ. Race Is Associated With Poor Outcomes in Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2016 Oct;96(2S):E407. Pubmedid: 27674609.
  • Naghavi AO, Gonzalez RJ, Scott JG, Abuodeh YA, Echevarria M, Mullinax JE, Ahmed KA, Harrison LB, Fernandez DC. Staged Reconstruction Brachytherapy Has Lower Overall Cost in Recurrent Soft Tissue Sarcoma. Int J Radiat Oncol Biol Phys. 2016 Oct;96(2S):E398-E399. Pubmedid: 27674581.
  • Naghavi AO, Strom T, Abuodeh YA, Frakes JM, Ahmed KA, Harrison LB, Trotti A, Caudell JJ. Risk Factors for Recurrence in Human Papillomavirus-Positive Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys. 2016 Oct;96(2S):E372-E373. Pubmedid: 27674513.
  • Naghavi AO, Strom T, Abuodeh YA, Echevarria M, Russell J, Kish JA, Balducci L, Trotti A, Harrison LB, Caudell JJ. Concurrent Chemotherapy in Elderly Patients With Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2016 Oct;96(2S):E362. Pubmedid: 27674484.
  • Mifsud MJ, Tanvetyanon T, Mccaffrey JC, Otto KJ, Padhya TA, Kish J, Trotti AM, Harrison LB, Caudell JJ. Adjuvant radiotherapy versus concurrent chemoradiotherapy for the management of high-risk salivary gland carcinomas. Head Neck. 2016 Nov;38(11):1628-1633. Pubmedid: 27098984.
  • Naghavi AO, Echevarria MI, Grass GD, Strom TJ, Abuodeh YA, Ahmed KA, Kim Y, Trotti AM, Harrison LB, Yamoah K, Caudell JJ. Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies. Cancer. 2016 Nov;122(22):3529-3537. Pubmedid: 27479362.
  • Parikh RR, Grossbard ML, Harrison LB, Yahalom J. Impact of delays in definitive treatment on overall survival: a National Cancer Database study of patients with Hodgkin lymphoma. Leuk Lymphoma. 2016 May;57(5):1074-1082. Pubmedid: 26374099.
  • Konski A, Yu JB, Freedman G, Harrison LB, Johnstone PA, Konski A, Yu JB, Freedman G, Harrison LB, Johnstone PA. Radiation Oncology Practice: Adjusting to a New Reimbursement Model. J Oncol Pract. 2016 May;12(5):e576-e583. Pubmedid: 27006359.
  • Ahmed KA, Stallworth DG, Kim Y, Johnstone PA, Harrison LB, Caudell JJ, Yu HH, Etame AB, Weber JS, Gibney GT. Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy. Ann Oncol. 2016 Mar;27(3):434-441. Pubmedid: 26712903.
  • Strom TJ, Caudell JJ, Harrison LB. Management of BCC and SCC of the Head and Neck. Cancer Control. 2016 Jul;23(3):220-227. Pubmedid: 27556662.
  • Naghavi AO, Strom TJ, Ahmed KA, Echevarria MI, Abuodeh YA, Venkat PS, Frakes JM, Harrison LB, Trotti AM, Caudell JJ. Management of Oropharyngeal Cancer in the HPV Era. Cancer Control. 2016 Jul;23(3):197-207. Pubmedid: 27556659.
  • Harrison LB, Caudell JJ. Maximizing Cures and Preserving Function in Head and Neck Cancers. Cancer Control. 2016 Jul;23(3):192. Pubmedid: 27556658.
  • Parikh RR, Grossbard ML, Harrison LB, Yahalom J. Association of intensity-modulated radiation therapy on overall survival for patients with Hodgkin lymphoma. Radiother Oncol. 2016 Jan;118(1):52-59. Pubmedid: 26522061.
  • Parikh RR, Grossbard ML, Harrison LB, Yahalom J. Early-stage nodular lymphocyte-predominant Hodgkin lymphoma: the impact of radiotherapy on overall survival. Leuk Lymphoma. 2016 Feb;57(2):320-327. Pubmedid: 26110882. Pmcid: PMC5593757.
  • Frakes JM, Naghavi AO, Demetriou SK, Strom TJ, Russell JS, Kish JA, McCaffrey JC, Otto KJ, Padhya TA, Harrison LB, Trotti AM, Caudell JJ. Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer. Cancer. 2016 Feb;122(4):634-641. Pubmedid: 26565997.
  • Ahmed KA, Abuodeh YA, Echevarria MI, Arrington JA, Stallworth DG, Hogue C, Naghavi AO, Kim S, Kim Y, Patel BG, Sarangkasiri S, Johnstone PA, Sahebjam S, Khushalani NI, Forsyth PA, Harrison LB, Yu M, Etame AB, Caudell JJ. Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy. Ann Oncol. 2016 Dec;27(12):2288-2294. Pubmedid: 27637745.
  • Naghavi AO, Echevarria MI, Strom TJ, Abuodeh YA, Ahmed KA, Venkat PS, Trotti A, Harrison LB, Green BL, Yamoah K, Caudell JJ. Treatment delays, race, and outcomes in head and neck cancer. Cancer Epidemiol. 2016 Dec;45:18-25. Pubmedid: 27664388.
  • Strojan P, Vermorken JB, Beitler JJ, Saba NF, Haigentz M, Bossi P, Worden FP, Langendijk JA, Eisbruch A, Mendenhall WM, Lee AW, Harrison LB, Bradford CR, Smee R, Silver CE, Rinaldo A, Ferlito A. Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review. Head Neck. 2016 Apr;38 Suppl 1:E2151-E2158. Pubmedid: 25735803.
  • Strom T, Harrison LB. Radiotherapy for management of basal and squamous cell carcinoma. Curr Prob Cancer. 2015 Sep;39(4):237-247. Pubmedid: 26364698.
  • Parikh RR, Grossbard ML, Green BL, Harrison LB, Yahalom J. Disparities in survival by insurance status in patients with Hodgkin lymphoma. Cancer. 2015 Oct;121(19):3515-3524. Pubmedid: 26058564.
  • Parikh RR, Grossbard ML, Harrison LB, Yahalom J. Early-Stage Classic Hodgkin Lymphoma: The Utilization of Radiation Therapy and Its Impact on Overall Survival. Int J Radiat Oncol Biol Phys. 2015 Nov;93(3):684-693. Pubmedid: 26279323.
  • Parikh RR, Moskowitz BK, Maher E, Della Rocca D, Della Rocca R, Culliney B, Shapira I, Grossbard ML, Harrison LB, Hu K. Long-term outcomes and patterns of failure in orbital lymphoma treated with primary radiotherapy. Leuk Lymphoma. 2015 May;56(5):1266-1270. Pubmedid: 25356924.
  • Ennis KY, Chen MH, Smith GC, D'Amico AV, Zhang Y, Quinn SA, Ryemon SN, Goltz D, Harrison LB, Ennis RD. The Impact of Economic Recession on the Incidence and Treatment of Cancer. J Cancer. 2015 Jun;6(8):727-733. Pubmedid: 26185534. Pmcid: PMC4504108.
  • Ko HC, Gupta V, Mourad WF, Hu KS, Harrison LB, Som PM, Bakst RL. A contouring guide for head and neck cancers with perineural invasion. Pract Radiat Oncol. 2015 Jul;4(6):e247-e258. Pubmedid: 25407876.
  • Prokopiou S, Moros EG, Poleszczuk J, Caudell J, Torres-Roca JF, Latifi K, Lee JK, Myerson R, Harrison LB, Enderling H. A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation. Radiat Oncol. 2015 Jul;10:159. Pubmedid: 26227259. Pmcid: PMC4521490.
  • Strojan P, Corry J, Eisbruch A, Vermorken JB, Mendenhall WM, Lee AW, Haigentz M, Beitler JJ, de Bree R, Takes RP, Paleri V, Kelly CG, Genden EM, Bradford CR, Harrison LB, Rinaldo A, Ferlito A. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate. Head Neck. 2015 Jan;37(1):134-150. Pubmedid: 24481720.
  • Gamez M, Hu K, Harrison LB. RETRACTED: Laryngeal Function After Radiation Therapy. Otolaryng Clin N Am. 2015 08;48(4):585-599. Pubmedid: 26092763.
  • Mourad WF, Hu KS, Puckett L, Hauerstock D, Shourbaji RA, Li Z, Manolidis S, Schantz S, Tran T, Jacobson A, Urken M, Culliney B, Persky M, Harrison LB. Five-year outcomes of squamous cell carcinoma of the tonsil treated with radiotherapy. Am J Clin Oncol. 2014 Feb;37(1):57-62. Pubmedid: 23357967.
  • Welk G, Fischman MG, Greenleaf C, Harrison L, Ransdell L, van der Mars H, Zhu W. Editorial Board Position statement regarding the Declaration on Research Assessment (DORA) recommendations with respect to journal impact factors. Res Q Exerc Sport. 2014 Dec;85(4):429-430. Pubmedid: 25412123.
  • Nicholas Lukens J, Gamez M, Hu K, Harrison LB. Modern brachytherapy. Semin Oncol. 2014 Dec;41(6):831-847. Pubmedid: 25499641.
  • Debenham BJ, Hu KS, Harrison LB. Present status and future directions of intraoperative radiotherapy. Lancet Oncol. 2013 Oct;14(11):e457-e464. Pubmedid: 24079873.
  • Mourad WF, Shasha D, Blakaj DM, Khorsandi AS, Shourbaji RA, Glanzman J, Kabarriti R, Young R, Patel S, Katsoulakis E, Gámez M, Woode R, Lazarus C, Concert C, Hu KS, Harrison LB. Comprehensive head and neck radiotherapy dose-volume constraints do not apply to smaller volumes. Anticancer Res. 2013 Oct;33(10):4483-4489. Pubmedid: 24123019.
  • Chadha M, Woode R, Sillanpaa J, Lucido D, Boolbol SK, Kirstein L, Osborne MP, Feldman S, Harrison LB. Early-stage breast cancer treated with 3-week accelerated whole-breast radiation therapy and concomitant boost. Int J Radiat Oncol Biol Phys. 2013 May;86(1):40-44. Pubmedid: 23290443.
  • Becker DJ, Talwar S, Levy BP, Thorn M, Roitman J, Blum RH, Harrison LB, Grossbard ML. Impact of oncology drug shortages on patient therapy: unplanned treatment changes. J Oncol Pract. 2013 Jul;9(4):e122-e128. Pubmedid: 23942928. Pmcid: PMC3710178.
  • Mourad WF, Hu KS, Shourbaji RA, Khorsandi A, Harrison LB. Cranial Nerves Contouring Among Patients Treated With IMRT for Base of Skull, Nasopharyngeal, and Paranasal Sinus Cancer. Pract Radiat Oncol. 2013 Apr;3(2 Suppl 1):S34. Pubmedid: 24674554.
  • Mourad WF, Shourbaji RA, Ishihara D, Lin W, Hu KS, Harrison LB. The impact of computed tomography on early glottic cancer outcomes. Pract Radiat Oncol. 2013 Apr;3(2 Suppl 1):S33. Pubmedid: 24674553.
  • Serra D, Parris CR, Carper E, Homel P, Fleishman SB, Harrison LB, Chadha M. Outcomes of guided imagery in patients receiving radiation therapy for breast cancer. Clin J Oncol Nurs. 2012 Dec;16(6):617-623. Pubmedid: 23178354.
  • Chadha M, Portenoy J, Boolbol SK, Gillego A, Harrison LB. Is there a role for postmastectomy radiation therapy in ductal carcinoma in situ?. Int J Surg Oncol. 2012 Aug;2012:423520. Pubmedid: 22778939. Pmcid: PMC3384903.
  • Chadha M, Young A, Geraghty C, Masino R, Harrison L. Image guidance using 3D-ultrasound (3D-US) for daily positioning of lumpectomy cavity for boost irradiation. Radiat Oncol. 2011 May;6:45. Pubmedid: 21554697. Pmcid: PMC3113959.
  • Furhang EE, Dolan J, Sillanpaa JK, Harrison LB. Automating the initial physics chart checking process. J Appl Clin Med Phys. 2009 Feb;10(1):2855. Pubmedid: 19223834. Pmcid: PMC5720507.
  • Mehta PS, Harrison LB. Function and organ preservation in adult cancers of the head and neck. Expert Rev Anticancer Ther. 2007 Mar;7(3):361-371. Pubmedid: 17338655.
  • Chiu-Tsao ST, Ho Y, Shankar R, Wang L, Harrison LB. Energy dependence of response of new high sensitivity radiochromic films for megavoltage and kilovoltage radiation energies. Med Phys. 2005 Nov;32(11):3350-3354. Pubmedid: 16370422.
  • Hu K, Harrison LB. Impact of anemia in patients with head and neck cancer treated with radiation therapy. CURR TREAT OPTION ON. 2005 Jan;6(1):31-45. Pubmedid: 15610713.
  • Shasha D, Cremieux P, Harrison L. Relationship between hemoglobin levels and quality of life during radiation therapy plus concomitant or sequential chemotherapy in patients with cancer and anemia treated with epoetin alfa. J Natl Compr Canc Ne. 2004 Sep;2(5):509-517. Pubmedid: 19780258.
  • Chiu-Tsao ST, Duckworth T, Zhang C, Patel NS, Hsiung CY, Wang L, Shih JA, Harrison LB. Dose response characteristics of new models of GAFCHROMIC films: dependence on densitometer light source and radiation energy. Med Phys. 2004 Sep;31(9):2501-2508. Pubmedid: 15487731.
  • Patel NS, Chiu-Tsao ST, Shih JA, Ho Y, Tsao HS, Harrison LB. Treatment planning dosimetric parameters for 192Ir seed at short distances: effects of air channels and neighboring seeds based on Monte Carlo study. Med Phys. 2004 Jun;31(6):1521-1528. Pubmedid: 15259656.
  • Chiu-Tsao ST, Duckworth TL, Patel NS, Pisch J, Harrison LB. Verification of Ir-192 near source dosimetry using GAFCHROMIC film. Med Phys. 2004 Feb;31(2):201-207. Pubmedid: 15000605.
  • Shaiova L, Lapin J, Manco LS, Shasha D, Hu K, Harrison L, Portenoy RK. Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis. Support Care Cancer. 2004 Apr;12(4):268-273. Pubmedid: 14750002.
  • Shasha D, George MJ, Harrison LB. Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy. Cancer. 2003 Sep;98(5):1072-1079. Pubmedid: 12942577.
  • Chiu-Tsao ST, Duckworth TL, Hsiung CY, Li Z, Williamson J, Patel NS, Harrison LB. Thermoluminescent dosimetry of the SourceTech Medical model STM1251 125I seed. Med Phys. 2003 Jul;30(7):1732-1735. Pubmedid: 12906190.
  • Maehara A, Patel NS, Harrison LB, Weissman NJ, Bui AB, Kim HS, Ajani AE, Castagna MT, McMillan TL, Yang N, Chan R, Pisch J, Quan H, Chiu-Tsao ST, Waksman R, Mintz GS. Dose heterogeneity may not affect the neointimal proliferation after gamma radiation for in-stent restenosis: a volumetric intravascular ultrasound dosimetric study. J Am Coll Cardiol. 2002 Jun;39(12):1937-1942. Pubmedid: 12084591.
  • Furhang EE, Hanley J, Chiu-Tsao ST, Toner S, Fan P, Gliedman P, Harrison LB. Clearance assurance for stereotactic radiosurgery and radiotherapy. Med Phys. 2002 Jan;29(1):45-50. Pubmedid: 11831572.
  • Harrison LB, Chadha M, Hill RJ, Hu K, Shasha D. Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist. 2002 Dec;7(6):492-508. Pubmedid: 12490737.
  • Harrison LB, Shasha D, Homel P. Prevalence of anemia in cancer patients undergoing radiotherapy: prognostic significance and treatment. Oncology-Basel. 2002;63 Suppl 2:11-18. Pubmedid: 12466640.
  • Wolden SL, Zelefsky MJ, Kraus DH, Rosenzweig KE, Chong LM, Shaha AR, Zhang H, Harrison LB, Shah JP, Pfister DG. Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. J Clin Oncol. 2001 Feb;19(4):1105-1110. Pubmedid: 11181675.
  • Patel NS, Chiu-Tsao ST, Williamson JF, Fan P, Duckworth T, Shasha D, Harrison LB. Thermoluminescent dosimetry of the Symmetra 125I model I25.S06 interstitial brachytherapy seed. Med Phys. 2001 Aug;28(8):1761-1769. Pubmedid: 11548947.
  • Shasha D, Harrison LB, Enker W. Brachytherapy in the treatment of colorectal malignancies. Hematol Oncol Clin North Am. 1999 Jun;13(3):559-575. Pubmedid: 10432429.
  • Hu KS, Harrison LB. Altered fractionation in the treatment of head and neck cancer. Curr Oncol Rep. 1999;1(2):110-123. Pubmedid: 11122807.
  • Shasha D, Harrison LB. Elective irradiation of the N0 neck in squamous cell carcinoma of the upper aerodigestive tract. Otolaryng Clin N Am. 1998 Oct;31(5):803-813. Pubmedid: 9735108.
  • Harrison LB, Zelefsky MJ, Pfister DG, Carper E, Raben A, Kraus DH, Strong EW, Rao A, Thaler H, Polyak T, Portenoy R. Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck. 1997 May;19(3):169-175. Pubmedid: 9142514.
  • Kraus DH, Zelefsky MJ, Brock HA, Huo J, Harrison LB, Shah JP. Combined surgery and radiation therapy for squamous cell carcinoma of the hypopharynx. Otolaryngol Head Neck Surg. 1997 Jun;116(6 Pt 1):637-641. Pubmedid: 9215375.
  • Kraus DH, Zelefsky MJ, Brock HAJ, Huo J, Harrison LB, Shah JP. Combined Surgery and Radiation Therapy for Squamous Cell Carcinoma of the Hypopharynx. Otolaryngol Head Neck Surg. 1997 Jun;116(6):637-641. Pubmedid: 29389278.
  • Pisters PW, Harrison LB, Leung DH, Woodruff JM, Casper ES, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 1996 Mar;14(3):859-868. Pubmedid: 8622034.
  • Armstrong JG, Zelefsky MJ, Leibel SA, Burman C, Han C, Harrison LB, Kutcher GJ, Fuks ZY. Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer. Ann Oncol. 1995 Sep;6(7):693-697. Pubmedid: 8664191.
  • Pfister DG, Harrison LB, Strong EW, Shah JP, Spiro RW, Kraus DH, Armstrong JG, Zelefsky MJ, Fass DE, Weiss MH. Organ-function preservation in advanced oropharynx cancer: results with induction chemotherapy and radiation. J Clin Oncol. 1995 Mar;13(3):671-680. Pubmedid: 7884428.
  • Anderson LL, Zlotolow IM, McCormick B, Harrison LB. Controlled mold geometry for surgical deficit treatment planning. Med Phys. 1995 Mar;22(3):307-311. Pubmedid: 7596320.
  • Nag S, Owen JB, Farnan N, Pajak TF, Martinez A, Porter A, Blasko J, Harrison LB. Survey of brachytherapy practice in the United States: a report of the Clinical Research Committee of the American Endocurietherapy Society. Int J Radiat Oncol Biol Phys. 1995 Jan;31(1):103-107. Pubmedid: 7995739.
  • Kraus DH, Pfister DG, Harrison LB, Spiro RH, Strong EW, Zelefsky M, Bosl GJ, Shah JP. Salvage laryngectomy for unsuccessful larynx preservation therapy. Ann Otol Rhinol Laryngol. 1995 Dec;104(12):936-941. Pubmedid: 7492064.
  • Pisters PW, Harrison LB, Woodruff JM, Gaynor JJ, Brennan MF. A prospective randomized trial of adjuvant brachytherapy in the management of low-grade soft tissue sarcomas of the extremity and superficial trunk. J Clin Oncol. 1994 Jun;12(6):1150-1155. Pubmedid: 8201376.
  • Kraus DH, Pfister DG, Harrison LB, Shah JP, Spiro RH, Armstrong JG, Fass DE, Zelefsky M, Schantz SP, Weiss MH. Larynx preservation with combined chemotherapy and radiation therapy in advanced hypopharynx cancer. Otolaryngol Head Neck Surg. 1994 Jul;111(1):31-37. Pubmedid: 8028939.
  • Sessions RB, Lerner DN, Harrison LB. A pivot-shifting palate flap for enhanced exposure of the posterior choanae and nasopharynx. Otolaryngol Head Neck Surg. 1993 Jul;109(1):96-100. Pubmedid: 8393168.
  • Harrison LB, Sessions RB, Fass DE, Armstrong JG, Hunt M, Spiro RH. Nasopharyngeal brachytherapy with access via a transpalatal flap. Am J Surg. 1992 Aug;164(2):173-175. Pubmedid: 1636898.
  • Brennan MF, Casper ES, Harrison LB, Shiu MH, Gaynor J, Hajdu SI. The role of multimodality therapy in soft-tissue sarcoma. Ann Surg. 1991 Sep;214(3):328-336. Pubmedid: 1929613. Pmcid: PMC1358657.
  • Leibel SA, Kutcher GJ, Harrison LB, Fass DE, Burman CM, Hunt MA, Mohan R, Brewster LJ, Ling CC, Fuks ZY. Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys. 1991 Apr;20(4):823-833. Pubmedid: 2004961.
  • Sessions RB, Harrison LB, Strong EW, Spiro RH. A management plan for tongue base cancer that includes brachytherapy. Otolaryngol Head Neck Surg. 1990 Oct;103(4):599-604. Pubmedid: 2123318.
  • Spiro RH, Kelly J, Vega AL, Harrison LB, Strong EW. Squamous carcinoma of the posterior pharyngeal wall. Am J Surg. 1990 Oct;160(4):420-423. Pubmedid: 2221247.
  • Goff PH, Harrison LB, Furhang E, Ng E, Bhatia S, Trichter F, Ennis RD. 2D kV orthogonal imaging with fiducial markers is more precise for daily image guided alignments than soft-tissue cone beam computed tomography for prostate radiation therapy. Adv Radiat Oncol. 2(3):420-428. Pubmedid: 29114611. Pmcid: PMC5605315.